Matthew B. Klein Insider Trading $PTCT PTC THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew B. Klein.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew B. Klein. Matthew B. Klein is Chief Development Officer in PTC THERAPEUTICS, INC. ($PTCT).

Matthew B. Klein in PTC THERAPEUTICS, INC.

Trading Symbol: PTCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew B. Klein: Chief Development Officer
Holdings: 18,450 shares
Current Value: $248,337
Latest Transaction: Apr 21 2021
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Matthew B. Klein in PTC THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 21 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS47.921979,44016,80917 K to 16.8 K (-1.16 %)
Apr 21 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS46.581,44467,26417,00618.5 K to 17 K (-7.83 %)
Apr 21 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS48.1785941,37618,45019.3 K to 18.5 K (-4.45 %)
Jan 20 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...Option ExerciseM38.984,300167,61486,314
Jan 20 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS69.094,300297,07819,30923.6 K to 19.3 K (-18.21 %)
Jan 20 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...BuyM38.984,300167,61423,60919.3 K to 23.6 K (+22.27 %)
Jan 12 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...Option ExerciseM38.985,500214,39090,614
Jan 12 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS70.321,500105,48619,30920.8 K to 19.3 K (-7.21 %)
Jan 12 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS69.484,000277,92420,80924.8 K to 20.8 K (-16.12 %)
Jan 12 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...BuyM38.985,500214,39024,80919.3 K to 24.8 K (+28.48 %)
Jan 08 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...Option ExerciseM39.983,886155,36296,114
Jan 08 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...Option ExerciseA66.4952,5003,490,72552,500
Jan 08 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...SellS68.983,886268,05619,30923.2 K to 19.3 K (-16.75 %)
Jan 08 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...BuyM38.983,886151,47623,19519.3 K to 23.2 K (+20.13 %)
Jan 08 2021PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...GrantA0.009,000019,30910.3 K to 19.3 K (+87.30 %)
Apr 17 2020PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...Option ExerciseA47.4950,0002,374,50050,000
Apr 17 2020PTCTPTC THERAPEUTICS, ...Klein Matthew B.Chief Development O ...GrantA0.0010,000010,0000 to 10 K

Page:   1